A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.

Frontiers in bioscience : a journal and virtual library

Volumn 7, Issue , 2002, Pages

  Ding, Shi Fa ^a   Lombardi, Rocco ^a   Nazari, Reza ^a   Joshi, Sadhna ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; GAG PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; CELL LINE; GENE THERAPY; GENE VECTOR; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; GENETICS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; METHODOLOGY; MOLONEY LEUKEMIA ONCOVIRUS; MUTATION; OPEN READING FRAME; T LYMPHOCYTE; VIROLOGY; VIRUS REPLICATION;

CELL LINE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; MOLONEY MURINE LEUKEMIA VIRUS; MUTATION; OPEN READING FRAMES; RNA, ANTISENSE; RNA, VIRAL; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 0036483517     PISSN: None     EISSN: 10934715     Source Type: Journal    
DOI: 10.2741/ding     Document Type: Article

References (0)